Skip to main content
PredictPedia
Market snapshot: . Prices may have changed since this snapshot.
Events
GroupKALSHI

FDA decision: Vamikibart by Genentech (on or before July 31, 2027)

FDA decision: Vamikibart by Genentech (on or before July 31, 2027)
Vol

K 0 contracts

|
Events

1

|
Markets

1

Kalshi

Current odds

Snapshot from

As of Oct 29, 2026, 12:00 AM UTC, the highest-priced outcome on Kalshi is a full approval or an accelerated approval at 50%.

Kalshi

  1. a full approval or an accelerated approval50%

Yes prices. They are not order quotes; check each platform's rules, fees and live prices before trading.

AI Analysis

Trader mode: Market mechanics, assumptions and risks

K 0 contracts

Reported volume · provider units

1

Saved contracts

0

Same-question pairs

Source snapshot: Oct 29, 2026, 12:00 AM UTC

About This Event

FDA decision on Vamikibart on or before July 31, 2027 If the FDA's decision on Vamikibart by Genentech on or before July 31, 2027 is a full approval or an accelerated approval, the market resolves to Yes. This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. This market will close early if the FDA issues a decision on Vamikibart before Aug 1, 2027

AI-generated analysis based on market data. Not financial advice.

AI-written background. References identify the evidence used; Wikipedia links under Learn More are additional reading. Prices and provider rules are dated snapshots. This is not financial advice.

Related prediction markets

Prices are catalog snapshots and may have changed. Check each market's rules and observation time.

KalshiFinancials
FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

K 0 contracts
What will the FDA's decision be on Tozorakimab by AstraZeneca on or before March 31, 2027?Yes 50%
1 mktNext deadline Apr 8, 2027 UTC
PolymarketKalshiPolitics
When will traffic at the Strait of Hormuz return to normal?

When will traffic at the Strait of Hormuz return to normal?

PM $19.35M · K 10.84M contracts

Strait of Hormuz traffic returns to normal by December 31?

Kalshi: Will the 7-day moving average of transit calls through the Strait of Hormuz as reported by the IMF PortWatch be above 60 before January 1, 2027?

Related contracts

PM Yes 11.5%Rules differK Yes 8.8%

Strait of Hormuz traffic returns to normal by October 31?

Kalshi: Will the 7-day moving average of transit calls through the Strait of Hormuz as reported by the IMF PortWatch be above 60 before November 1, 2026?

Related contracts

PM Yes 0.4%Rules differK Yes 0.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

2 saved comparisonsNext deadline Nov 1, 2026 UTC
PolymarketTech
FDA approves skin cancer vaccine by...?

FDA approves skin cancer vaccine by...?

PM $217.5K
Skin cancer vaccine FDA approved by December 31, 2027?Yes 63.5%
Skin cancer vaccine FDA approved by September 30, 2027?Yes 28.5%
Skin cancer vaccine FDA approved by June 30, 2027?Yes 13.5%
3 mktsNext deadline Jul 1, 2027 UTC
KalshiFinancials
FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

K 0 contracts
What will the FDA's decision be on Ralinepag by United Therapeutics on or before June 24, 2027?Yes 50%
1 mktNext deadline Jul 2, 2027 UTC
KalshiFinancials
FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

K 0 contracts
What will the FDA's decision be on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027?Yes 50%
1 mktNext deadline Feb 6, 2027 UTC
KalshiFinancials
DDR5 16Gb (2Gx8) eTT · Average price in July 2027

DDR5 16Gb (2Gx8) eTT · Average price in July 2027

K 976 contracts
Will the monthly average spot price of DDR5 16Gb (2Gx8) eTT be above $24.60 in July 2027?Yes 97.5%
Will the monthly average spot price of DDR5 16Gb (2Gx8) eTT be above $24.50 in July 2027?Yes 97.5%
Will the monthly average spot price of DDR5 16Gb (2Gx8) eTT be above $24.40 in July 2027?Yes 97.5%
+37 moreNext deadline Aug 8, 2027 UTC

Market Insights

Price gaps of 2 pp+

0

Same-question pairs

0

No outcomes on this page have been reviewed as the same question on both platforms yet.

Price differences do not establish arbitrage. Check each pair's review, current order prices, fees and settlement rules.

Trade This Market

Trade on Kalshi